Curaleaf Holdings Files 6-K Report

Ticker: CURLF · Form: 6-K · Filed: 2025-09-09T00:00:00.000Z

Sentiment: neutral

Topics: reporting, sec-filing, legal

TL;DR

Curaleaf filed a 6-K on 9/9/25, confirming 40-F annual report status.

AI Summary

Curaleaf Holdings, Inc. filed a Form 6-K on September 9, 2025, reporting for the month of September 2025. The filing indicates that Curaleaf is a foreign private issuer and will file annual reports under Form 40-F. Peter Clateman, Chief Legal Officer, signed the report on behalf of the company.

Why It Matters

This filing provides an update on Curaleaf's reporting status as a foreign private issuer, which can affect how investors interpret their financial disclosures.

Risk Assessment

Risk Level: low — This is a routine administrative filing and does not contain material financial or operational news.

Key Players & Entities

FAQ

What is the primary purpose of this Form 6-K filing?

The primary purpose of this Form 6-K filing is to report for the month of September 2025 and to indicate that Curaleaf Holdings, Inc. will file annual reports under Form 40-F.

Who signed this report on behalf of Curaleaf Holdings, Inc.?

Peter Clateman, Chief Legal Officer, signed the report on behalf of Curaleaf Holdings, Inc.

What is Curaleaf Holdings, Inc.'s principal executive office address?

Curaleaf Holdings, Inc.'s principal executive office is located at 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8, Canada.

What is the SEC file number for Curaleaf Holdings, Inc.?

The SEC file number for Curaleaf Holdings, Inc. is 333-249081.

Does Curaleaf Holdings, Inc. file annual reports under Form 20-F or Form 40-F?

Curaleaf Holdings, Inc. will file annual reports under Form 40-F.

From the Filing

0001756770-25-000032.txt : 20250909 0001756770-25-000032.hdr.sgml : 20250909 20250909123248 ACCESSION NUMBER: 0001756770-25-000032 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 4 CONFORMED PERIOD OF REPORT: 20250908 FILED AS OF DATE: 20250909 DATE AS OF CHANGE: 20250909 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Curaleaf Holdings, Inc. CENTRAL INDEX KEY: 0001756770 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 333-249081 FILM NUMBER: 251302470 BUSINESS ADDRESS: STREET 1: 420 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10170 BUSINESS PHONE: 781-451-0117 MAIL ADDRESS: STREET 1: 420 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10170 FORMER COMPANY: FORMER CONFORMED NAME: LEAD VENTURES INC. DATE OF NAME CHANGE: 20181023 6-K 1 a6-kcover09082025tsxcompos.htm 6-K Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September, 2025 Commission File Number: 333-249081 Curaleaf Holdings, Inc. (Name of Registrant) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8, Canada (Address of Principal Executive Office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F ☐    Form 40-F ☒ SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. CURALEAF HOLDINGS, INC. (Registrant) Date: September 9, 2025 By: /s/ Peter Clateman Name: Peter Clateman Title: Chief Legal Officer EXHIBIT INDEX Exhibit Number Description 99.1 Press Release EX-99.1 2 a2025-09x08xcuraleafxjoi.htm EX-99.1 a2025-09x08xcuraleafxjoi Curaleaf Holdings, Inc. Investor Relations Curaleaf Joins S&P/TSX Composite Index Inclusion in Canada's benchmark index increases exposure and broadens access across North American capital markets Curaleaf becomes sole cannabis sector representative in the index after latest rebalance STAMFORD, Conn., Sept. 8, 2025 /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announced that it has been selected for inclusion into the S&P/TSX Composite Index under the Health Care sector, effective prior to the open of trading on Monday, September 22, 2025. This inclusion positions the Company among the highest-capitalized and most actively traded stocks on the Toronto Stock Exchange. As the first U.S.-based cannabis operator to be included in the S&P/TSX Composite Index, the Company is poised to gain increased visibility and credibility within one of North America's premier equity benchmarks. "This marks a pivotal moment for Curaleaf and represents a significant moment for mainstream normalization across the broader cannabis industry," said Boris Jordan, Chairman and CEO of Curaleaf. "Being recognized among some of the most influential stocks in North America, and as the only U.S.-based cannabis operator currently in this index, validates our sector's growing legitimacy and long-term potential. Our inclusion reflects an expanded presence in public markets and broadens our access to institutional investment and index-linked vehicles as we navigate the industry's ongoing development, alongside potential regulatory catalysts. Our team's dedication has been the driving force behind this achievement, and I would like to extend my thanks to the Curaleaf team for their hard work and commitment." About Curaleaf Holdings Curaleaf Holdings, Inc. (TSX:

View on Read The Filing